Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
- PMID: 29505935
- DOI: 10.1016/j.ejmech.2018.02.065
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
Abstract
The indole scaffold is one of the most widespread heterocycles in the naturally occurring and synthetic bioactive compounds including anticancer agents. Due to its biodiversity and versatility, it has been a highly privileged motif for the target-based design and development of anticancer agents. In the last decade, many researchers have reported various indole-based compounds with distinct mechanisms involved in producing potential anticancer activities, indicating the importance of indole motif in the anticancer drug development. The present article aims to review the current application of indole core in the design of new anticancer agents that may act via various targets such as histone deacetylases (HDACs), sirtuins, PIM kinases, DNA topoisomerases and σ receptors. Targeting these enzymes or receptors in cancer cells by indole-derived compounds can be a powerful tool for the management of cancer.
Keywords: Anti-cancer; Cytotoxic activity; Drug design; Indole.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Indole: A privileged scaffold for the design of anti-cancer agents.Eur J Med Chem. 2019 Dec 1;183:111691. doi: 10.1016/j.ejmech.2019.111691. Epub 2019 Sep 11. Eur J Med Chem. 2019. PMID: 31536895 Review.
-
Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents, an update (2013-2015).Future Med Chem. 2016 Jul;8(11):1291-316. doi: 10.4155/fmc-2016-0047. Epub 2016 Jul 20. Future Med Chem. 2016. PMID: 27476704 Review.
-
Indole-fused azepines and analogues as anticancer lead molecules: Privileged findings and future directions.Eur J Med Chem. 2017 Dec 15;142:244-265. doi: 10.1016/j.ejmech.2017.07.042. Epub 2017 Aug 4. Eur J Med Chem. 2017. PMID: 28803677 Review.
-
Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino[1,2-a]indol-1(2H)-ones as potential anticancer agents effecting the reactive oxygen species production.Eur J Med Chem. 2018 Feb 25;146:260-273. doi: 10.1016/j.ejmech.2018.01.042. Epub 2018 Jan 31. Eur J Med Chem. 2018. PMID: 29407956
-
Indole molecules as inhibitors of tubulin polymerization: potential new anticancer agents.Future Med Chem. 2012 Oct;4(16):2085-115. doi: 10.4155/fmc.12.141. Future Med Chem. 2012. PMID: 23157240 Review.
Cited by
-
Indole-Based Tubulin Inhibitors: Binding Modes and SARs Investigations.Molecules. 2022 Feb 28;27(5):1587. doi: 10.3390/molecules27051587. Molecules. 2022. PMID: 35268688 Free PMC article. Review.
-
Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds.Cancers (Basel). 2023 Aug 5;15(15):3980. doi: 10.3390/cancers15153980. Cancers (Basel). 2023. PMID: 37568796 Free PMC article. Review.
-
3-Indoleacetonitrile Is Highly Effective in Treating Influenza A Virus Infection In Vitro and In Vivo.Viruses. 2021 Jul 23;13(8):1433. doi: 10.3390/v13081433. Viruses. 2021. PMID: 34452298 Free PMC article.
-
Synthesis and Anticancer Activity of Indole-Functionalized Derivatives of Betulin.Pharmaceutics. 2022 Nov 4;14(11):2372. doi: 10.3390/pharmaceutics14112372. Pharmaceutics. 2022. PMID: 36365190 Free PMC article.
-
Novel organophosphorus aminopyrimidines as unique structural DNA-targeting membrane active inhibitors towards drug-resistant methicillin-resistant Staphylococcus aureus.Medchemcomm. 2018 Aug 1;9(9):1529-1537. doi: 10.1039/c8md00301g. eCollection 2018 Sep 1. Medchemcomm. 2018. PMID: 30288226 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information